Women's Health Essentials: On Demand
|
$399.20
Use promo code (Limited Time Offer)
15 CREDITS
  Hurry! Offer expires January 1, 2023 at 11:59 pm ET!
|
|
A collection of recorded video lectures from recent conferencesCourse Content
| Session | Title | Faculty |
| Session 1 (59 minutes) | Polycystic Ovary Syndrome (PCOS): It’s Not as Complicated as it Seems | Anita Nelson, MD |
| Session 2 (65 minutes) | Contraceptive Update: New Methods, New Practices | Anita Nelson, MD |
| Session 3 (58 minutes) | Heart Disease in Women: Sex Matters | Karol Watson, MD |
| Session 4 (57 minutes) | Cardio-Obstetrics: The Heart and Pregnancy | Karol Watson, MD |
| Session 5 (66 minutes) | Boning Up on Osteoporosis: It’s Not Just About the T-score | David Plourd, MD |
| Session 6 (64 minutes) | Applying New Guidelines in Management of Menopause | Michael S. Policar, MD, MPH |
| Session 7 (58 minutes) | Abnormal Vaginal Bleeding: New Names, New Treatments | Michael S. Policar, MD, MPH |
| Session 8 (57 minutes) | Breast Cancer Screening and Prevention | Anita Nelson, MD |
| Session 9 (46 minutes) | Cervical Cancer Screening and Prevention - Why the Guidelines Had to Change.... Again! | David Plourd, MD |
| Session 10 (39 minutes) | Weight Gain During Puberty, Pregnancy and Perimenopause | Donna H. Ryan, MD, FACP |
| Session 11 (63 minutes) | The Role of Lifestyle Interventions in Obesity Care and Management Real World Approaches to Produce Gold Standard Results | Donna H. Ryan, MD, FACP |
| Session 12 (60 minutes) | Bioidentical Hormone Therapy | Julia Files, MD |
| Session 13 (41 minutes) | Genitourinary Syndrome of Menopause: New Name...New Treatments | Julia Files, MD |
| Session 14 (47 minutes) | Perimenopausal Mood Disorders: A Clinician's Guide to Identification and Treatment | D. (Kay) Roussos-Ross, MD |
| Session 15 (40 minutes) | Recognizing and Treating Premenstrual Dysphoric Order (PMDD) | D. (Kay) Roussos-Ross, MD |
| Session 16 (30 minutes) | I'm Pregnant and I Can't Stop Vomiting | David Weismiller, MD |
| Session 17 (41 minutes) | "Three STIs Hit All Time High..." | David Weismiller, MD |
Program Overview
Presented by Continuing Education Company (CEC) for the past 26 years, our Primary Care CME Conference Series is designed to update primary care clinicians in rapidly changing therapeutic areas. This CME activity is comprised of recorded video lectures from recent conferences and will focus on timely and practical issues involving women’s health. An emphasis will be placed on recent advances, up-to-date practices, and guidelines that will enable participants to deliver optimal care for their female patients.
Learning Objectives:
As a result of this educational activity, participants should be better able to:
- Assess and provide female patients with an accurate diagnosis and optimal care for a broad range of disorders seen in primary care.
- Utilize current guidelines in the diagnosis and management of commonly encountered therapeutic issues throughout a women’s life cycle.
- Formulate comprehensive evidence-based interventions and treatment strategies that will lead to the reduction of modifiable risk factors and improved long term outcomes.
Post-Test and Evaluation:
After completing the CME activity, you must successfully complete a post-test and fill out a program evaluation form. You will then be able to view and print your CME certificate. Login into CME365 to view your transcript and reprint your certificate at any time.
Faculty
Julia A. Files, MD, FACP
Associate Professor of Medicine
Mayo Clinic Department of Medicine
Consultant, Medallion Program
Mayo Clinic Arizona
Scottsdale, AZ
Anita L. Nelson, MD
Professor Emeritus, Obstetrics and Gynecology
David Geffen School of Medicine at UCLA
Clinical Professor Obstetrics and Gynecology
University Southern California
Professor and Chair of Obstetrics and Gynecology
Western University of Health Sciences
Torrance, CA
David M. Plourd, MD, FACOG
Staff Obstetrician & Gynecologist & Obstetric Hospitalist
Formerly Naval Hospital
San Diego, CA
Michael S. Policar, MD, MPH
Professor Emeritus of OB, GYN, and Reproductive Sciences
University of California, San Francisco School of Medicine
San Francisco, CA
Dikea (Kay) Roussos-Ross, MD
Associate Professor
Division Director Gynecology, Gynecologic Surgery, and Obstetrics
Department of Obstetrics and Gynecology
University of Florida College of Medicine
Gainesville, FL
Donna H. Ryan, MD, FACP
Professor Emerita
Pennington Biomedical Research Center
Baton Rouge, LA
Karol E. Watson, MD, PhD, FACC
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women's Heart Health Program
David Geffen School of Medicine at UCLA
John Mazziotta, M.D., Ph.D. Term Chair in Medicine
Los Angeles, CA
David G. Weismiller, MD, ScM, FAAFP
Professor, Department of Family and Community Medicine
University of Nevada School of Medicine
Las Vegas, NV
Accreditation
AMA PRA Category 1 Credits™: Continuing Education Company, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education Company designates this enduring material for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 15 hours of Category 1 credit for completing this activity.
AANPCB: The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Nurse Practitioners may receive a maximum of 15 hours of participation, 7.5 of which can be used towards Pharmacology, for completing this activity.
Release Date: 2/20/2020
Expiration Date: 2/20/2023
Medium: Internet/Enduring Material, Video/Audio
Faculty/Planning Committee Disclosures
Review and Planning Committee Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) has no relevant financial relationships with a commercial interest that may impact upon this CME activity:
- Ronald Jendry, MD - Reviewer
- Walter Ejnes, CHCP - Reviewer & Planning Committee (Continuing Education Company)
- Beth Townsend - Reviewer (Continuing Education Company)
- Su Barnwell - Planning Committee (Continuing Education Company)
Faculty Disclosures:
The following individuals have indicated that he/she (nor spouse/partner) have no relevant financial relationships with a commercial interest that may impact upon this CME activity:
| Faculty | Disclosure |
| Julia Files, MD | Nothing to Disclose |
| Anita Nelson, MD | Advisory Board, Consultant, Research Grant, Grant Recipient: Agile Therapuetics Advisory Board, Consultant: AMAG Pharma, PharmaNest Consultant: American Regent Advisory Board, Consultant, Speakers Bureau: Avion Pharma, Cooper Surgical Advisory Board, Consultant, Speakers Bureau, Honoraria: Bayer Advisory Board, Consultant, Grant Recipient: ContraMed/Sebela Grant Recipient: Evofem, FHI (MonaLisa) Advisory Board, Consultant, Grant Recipient, Honoraria, Speakers Bureau: Merck |
| David Plourd, MD | Nothing to Disclose |
| Michael S. Policar, MD, MPH | Nothing to Disclose |
| Dikea (Kay) Roussos-Ross, MD | Nothing to Disclose |
| Donna H. Ryan, MD, FACP | Consultant: Alyvent, Amgen, Bausch Health, Boehringer-Ingelheim, IFA Celtic, KVK Tech, Quintiles, Real Appeal, Sanofi Aventis Consultant, Ownership Interest: Epitomee, Phenomix, ReDesign Health, Scientific Intake Advisory Board, Consultant, Ownership Interest: Gila Therapeutics Advisory Board: Janssen Advisory Board, Consultant, Speakers Bureau Research (SELECT Steering Committee): Novo Nordisk |
| Karol Watson, MD | Consultant: Amarin, Amgen, Boehringer-Ingelheim, Esperion Research Grant: National Institute of Diabetes and Digestive Kidney (NIDDK): R01DK 066013, NHLBI (SPRINT), NIH-BD2K |
| David Weismiller, MD | Nothing to Disclose |
Unlabeled Use Declaration:
During their presentation, faculty may discuss unlabeled or investigational use which is not approved for a commercial product. Faculty members are required to disclose this information to the audience when referring to an unlabeled or investigational use.
Statement of Disclosure and Independence:
It is the policy of Continuing Education Company (CEC) to ensure all of its accredited educational activities are designed, implemented, and evaluated in accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Criteria and Policies. In accordance with ACCME requirements, CEC has Relevant Financial Relationship Disclosure Policies that are designed to ensure that accredited educational activities are fair, balanced, independent, evidence based, and based on scientific rigor.
All individuals who are in position to influence and/or control content of a CEC accredited Continuing Medical Education (CME) activity must disclose any relevant financial interest or other relationships they have with an ineligible company, which is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Relevant financial interest or other relationship includes such things as grants or research support, employee, consultant, major stockholder, member of speakers’ bureau, etc.) The intent of this disclosure is to provide activity participants with information to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusions. All relevant financial relationships have been identified, mitigated, and are listed above.
The opinions, ideas, recommendations, and perspectives expressed in the syllabus and accompanying presentations at this activity are those of the program authors and presenting faculty only and do not necessarily reflect the opinions, ideas, recommendations or perspectives of their affiliated institutions, Continuing Education Company, advisory boards or consultants.
Computer Requirements
Flash Player 10 or later, and one of the following browsers:
- Windows: Internet Explorer 6 and later, Microsoft Edge (latest version), Firefox 1.x and later, Google Chrome (latest version), Opera 9.5 and later
- Mac: Safari 3 and later, Firefox 1.x and later, Google Chrome (latest version)
- Linux: Firefox 1.x and later
HTML5 via one of the following browsers:
- Windows: Google Chrome (latest version)
- Mac: Safari 6.0.5 or later, Google Chrome (latest version)
- Mobile: Safari in Apple iOS 6 or later
30 Day Money Back Guarantee
CEC stands behind our product. If you are not satisfied with your online course for any reason, send a written cancellation request and reason to registration@cmemeeting.org within 30 days of the purchase date for a full refund. (Cancellations on CME365™ Collection Series will incur a 5% processing fee.) Please note you may watch any of the content but once you claim credit for any online course, no refund can be granted.